Fifteen patients with Parkinson's disease and levodopa-induced motor fluctuations, were studied with repeated injections of apomorphine using two protocols to explore possible changes in the duration of motor response. One involved different interdose intervals; in the other, doses were given when the motor effects induced by the previous dose had just worn 60, range 41-76) were studied. The mean duration of disease was 14 years (7-23), mean duration of levodopa treatment 11 years (5-16), mean Hoehn and Yahr score when "off" 4 3, and the mean duration of motor fluctuations 5-5 years (2-8). On the basis of "on/off" charts and patient histories, 13 patients had complex fluctuations, with a mixture of predictable end of dose "wearing-off" and random motor swings with occasional failure to respond to individual levodopa doses. Two had pure "wearing-off" effects. Six were using intermittent subcutaneous apomorphine and one was using subcutaneous apomorphine via an infusion pump. Fourteen patients were taking levodopa, four bromocriptine and four selegiline. "On" period dyskinesias were present in all patients and "off" period dystonia was present in 11.
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Anti-Parkinsonian medication was discontinued nine to 12 hours before the study and the patients were given domperidone (20mg three times per day) for at least three days before testing. The study dose for each patient was determined before the day of testing by a stepwise increase in apomorphine to establish a dose which consistently switched the patient from their "off" state to their usual levodopainduced "on" state for a stable period of at least 20 minutes.
Studies began between 8 and 9 am. Eight patients were given an initial dose of apomorphine followed by two further boluses at two hourly intervals and three more doses at hourly intervals. The seven other patients and one patient who had already participated in the first protocol, were given apomorphine injections timed to the wearing offofthe motor effect ofthe previous dose. In these patients, following the first dose, six subsequent injections were given, each five minutes after the termination of the motor response to the previous dose. In cases when a bolus failed to produce a motor response, the next apomorphine dose was given one hour after the previous injection.
Motor response was assessed by measuring alternate unilateral hand tapping for 30 seconds on digital counters mounted 20 cm apart, timed walking over a 12 metre distance, or by a modified Webster disability scale,6 whichever gave the best indication of the patients "on" and "off" state during previous days of testing. The time to onset of motor effect, and the duration of action of each bolus were recorded. Patients were allowed a light breakfast and Table Duration 1  1 1  31  10  50  8  12  5  45  5  35  10  33  2  17  26  17  23  20  25  25  28  20  23  13  23  3  10  58  10  77  11  63  10  65  12  72  ND  ND  4  9  66  12  78  15  45  18  37  10  60  ND  ND  5  0  0  18  15  14  26  10  25  22  10  19  36  6  10  50  12  56  13  52  13  44  12  52  ND  ND  7  10  50  10  48  10  60  15  50  10  53  8  107  8  10  53  8  40  8  40  8  52  5  48  7 lunch at usual hospital meal times and activity was kept to a minimum during the test period.
Student's t test for paired data was used to compare the duration of action with different interdose intervals and with repeated doses of apomorphine. Correlation coefficients were calculated to assess any possible relationship between the latency and duration of each response throughout the test.
Results
The mean dose of apomorphine was 3-4 mg
(1-5), 52-3 pg/kg, being almost identical in the two groups of patients studied. The quality of the "on" state for each individual patient was consistent throughout the test period.
Using the first protocol we found no significant trend in the response duration with 
